Back to top
more

Saratoga Advantage Tr Health & Biotechnology Port Cl A: (MF: SHPAX)

(NASDAQ Mutual Funds) As of Jun 8, 2026 06:14 PM ET

$21.21 USD

-0.29 (-1.35%)

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

4-Sell of 5       4  

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Apr 30, 2026

Total Return %* Percentile Rank Objective
YTD -1.45 30
3 months -3.00 39
6 months 5.19 31
1 Year 13.13 50
3 Year 5.85 47
5 Year 4.79 34
10 Year 5.61 96

* Annual for three years and beyond.

Zacks Premium Research for SHPAX

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Sell 4
MF Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

% Unrealized Gain 48.47
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 4/30/2026 4.74
% Turnover 4/30/2026 22.00

Risk

3 Year 5 Year 10 Year
Beta 0.46 0.58 0.67
Alpha -5.85 -3.85 -4.66
R Squared 0.18 0.36 0.49
Std. Dev. 13.56 14.86 14.63
Sharpe 0.07 0.11 4.00

Sector / Country Weightings

As of 4/30/2026 % of Portfolio
Health 54.80
Retail Trade 18.06
Services 15.53
Finance 4.62
Technology 4.28
Other 2.15
Industrial Cyclical 0.56

Portfolio Holdings

Top Equity Holdings
(As of 2/28/2026)		 % of Portfolio Value (Mil$)
CARDINAL HEALTH INC 6.78 0.79
AMGEN INC 5.86 0.68
MCKESSON CORP 5.88 0.68
AMERISOURCEBERGEN CORP 5.40 0.63
JAZZ PHARMACEUTICALS PLC 5.31 0.62
UNITED THERAPEUTICS 5.04 0.58
NOVARTIS AG ADR 4.56 0.53
REGENERON PHARMACEUTICALS 4.51 0.52
GILEAD SCIENCES INC 3.94 0.46

Stock Holding % of Net Assets

As Of 2/28/2026
Total Issues 28
Avg. P/E 22.09
Avg. P/Book 3.76
Avg. EPS Growth 12.12
Avg. Market Value (Mil $) 140,327

Composition

% of Portfolio
Stocks 97.85
Foreign Stocks 13.06
Cash 2.53
Bonds 0.00
Foreign Bonds 0.00
Preferred 0.00
Convertible 0.00
Other -0.38
Foreign Hedged 0.00

Style Analysis

% of Portfolio
Large Growth 0.66
Large Value 6.69
Small Growth 0.46
Small Value 0.00
Foreign Stock 0.46
Emerging Market 0.30
Precious Metal 0.07
Intermediate Bond 20.28
Foreign Bond 4.59
High Yield Bond 0.00